Free Trial

Genetic Technologies (GENE) News Today

$1.98
+0.04 (+2.06%)
(As of 05/31/2024 ET)
Appendix 4C & Quarterly Business Update – March 2024
Appendix 4C & Quarterly Business Update – March 2024
ADRs End Lower; Genetic Technologies Declines 23%
Get Genetic Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter.

The #1 Crypto That You Don’t Own… Yet (Ad)

There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.

Click here for all the details…

GENE Media Mentions By Week

GENE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GENE
News Sentiment

0.12

0.76

Average
Medical
News Sentiment

GENE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GENE Articles
This Week

7

2

GENE Articles
Average Week

Get Genetic Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GENE) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners